Lisa Wilson founded In-Site Communications in 1995. She provides senior level strategic counsel, and hands-on implementation required to successfully execute custom-tailored programs for each client. Her extensive knowledge of the pharmaceuticals, medical devices and healthcare services industries gives In-Site a leading edge over others firms in the industry.
Lisa’s expertise is well-known on Wall Street and in the investment communities of significant financial centers worldwide. She is able to leverage her comprehensive understanding of the capital markets and long-standing relationships to benefit In-Site’s clients. She has successfully introduced numerous clients to high profile institutional investors, resulting in significant stock purchases.
Prior to starting In-Site, Lisa was a Vice President at Morgen-Walke Associates, Inc., where she managed the healthcare investor relations group. Lisa provided strategic direction for clients in the pharmaceuticals, generics, drug delivery and medical devices fields. She supervised a team focused on planning and conducting comprehensive investor relations activities for numerous companies, most notably Biovail, Teva Pharmaceuticals and Watson Pharmaceuticals.
Before entering the field of investor relations, Lisa was a healthcare equity analyst at Kidder, Peabody & Co., where she covered the specialty pharmaceuticals, drug delivery and generic drug sectors. Her coverage universe encompassed Alza, Alpharma, Dura, Elan, Forest Labs, KV Pharmaceutical, Marsam, Mylan, Teva Pharmaceuticals and Zenith. This experience on the sell-side helped establish Lisa as an expert in the healthcare field.
Lisa holds a B.A. from New York University and an M.B.A. in Finance from New York University’s Leonard N. Stern School of Business.
Amy Raskopf has focused exclusively on investor relations and corporate communications for companies in the healthcare sector for over ten years. Raised in a family of scientists, she is committed to applying her talents to benefit companies whose products or services have the potential to significantly improve modern medicine.
Amy supports the successful execution of programs designed to increase In-Site clients' visibility and credibility among the financial community. She has direct responsibility for the implementation and execution of investor relations programs and strategies for the firm's biotechnology, healthcare services, medical device and pharmaceutical clients. In addition to developing and implementing messaging platforms, she provides crisis communications counsel and is a talented financial writer.
Additionally, since 2006 Amy has been a consultant to Columbia Laboratories, Inc., a specialty pharmaceutical company, working closely with senior management to achieve their investor relations and corporate communications goals. She was Columbia's Manager, Investor Relations from 2004-2006 and continues to serve as Columbia's key communications point person with corporate partners, the NIH/NICHD, and research institutions, and as Columbia's spokesperson of record with media (national and regional). She has developed and executed communications strategy and messaging for internal and external audiences for a broad spectrum of corporate events including major partnerships, reporting of pivotal Phase III data, and crisis communications, and has built and maintained long-term, productive relationships with sell-side analysts and institutional investors.
Amy began her career at Ogilvy Public Relations Worldwide, ultimately executing investor relations and corporate communications programs for biotechnology, drug delivery and pharmaceutical companies, among others. She holds a B.A. from Smith College and an M.F.A. from Southern Methodist University.
Ilanit Allen is an experienced corporate communications specialist. She draws upon nearly 20 years of experience advising executives in the financial services, internet, pharmaceutical and retail sectors. Throughout her career, Ilanit has focused on assisting executives in crafting and positioning key messages for various audiences. She began her career as an investment banker focused on mergers and acquisitions and is attuned to communicating with Wall Street. She has worked with companies large and small, public and private, including: American Express, Johnson & Johnson, Société Générale and many startups.
Ilanit studied finance and international relations at the The Wharton School at the University of Pennsylvania. She received her M.B.A. from Harvard Business School.
Elizabeth (Libby) St. John has more than 25 years experience as a marketing communications professional, the last five of which have been dedicated to healthcare investor relations.
Libby began her career in book and magazine publishing, first on the editorial side, then moving to author promotion, where she worked with (among other authors) Mickey Mantle, Norman Mailer, Shana Alexander, Pierre Salinger and the former First Lady Barbara Bush. She then worked at the New School for Social Research as the Associate Director of Public Relations, responsible for promoting the adult-education programs as well as the music and fashion curricula. She continued in public relations at a privately-held computer consulting firm and then joined the insurance firm formerly known as Johnson & Higgins (now Marsh) as a marketing communications professional and was promoted to Vice President, Corporate Communications.
In March 2004, Libby joined In-Site, where she manages the day-to-day implementation of client investor-relations programs. Her key responsibilities include developing strategic messaging; creating communications materials, including press releases, annual reports, slide presentations and other marketing documents; soliciting client participation at industry-sponsored investor conferences, investor day events and non-deal roadshows, targeting both the buy- and sell-side; and maintaining a client-specific institutional-investor database.
Libby holds a BA in English from Boston College.
Jay Winer has more than 30 years of marketing-communications
experience, including a decade as a consultant for risk managers Johnson
& Higgins and Marsh, for whom he created health-industry-related
marketing materials. His other clients have included a wide array of
major corporations, including IBM, British Telecom, and ExxonMobil.